Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | HNF4A | P41235 | 1/20 | 0.46 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.45 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | FABP3 | P05413 | 1/20 | 0.43 |
| ▸ | FABP4 | P15090 | 1/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.43 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.43 |
| ▸ | BRS3 | P32247 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GALR3 | O60755 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anthranilic Acid SCHEMBL9173369 | 0.82 | BCAT2 (0.60) | HNF4ABCAT2ALDH1A1FABP3FABP4 | |
| Benzoic Acid SCHEMBL8919114 | 0.79 | ESR2 (0.58) | ESR2PTPN5GRIA2GRIA4FFAR1 | |
| SCHEMBL1343584 | 0.79 | CYP3A4 (0.49) | ESR2HNF4AALDH1A1BRS3GAA | |
| SCHEMBL29662886 | 0.78 | ESR2 (0.69) | ESR2PTPN5ALDH1A1HSD17B10GAA | |
| Water SCHEMBL3178714 | 0.78 | ESR2 (0.69) | ESR2PTPN5ALDH1A1HSD17B10GAA | |
| Anthranilic Acid SCHEMBL7609536 | 0.78 | ALDH1A1 (0.62) | ALDH1A1HSD17B10GAAKDM4EHPGD | |
| SCHEMBL223 | 0.78 | ESR2 (0.69) | ESR2PTPN5ALDH1A1HSD17B10GAA | |
| Anthranilic Acid SCHEMBL28896360 | 0.78 | ALDH1A1 (0.62) | ALDH1A1HSD17B10GAAKDM4EHPGD | |
| SCHEMBL10697723 | 0.77 | CYP3A4 (0.47) | ESR2HNF4AALDH1A1BRS3GAA | |
| SCHEMBL31299001 | 0.77 | HNF4A (0.56) | ESR2HNF4ABCAT2ALDH1A1FABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2673274-B1 | AN IMPROVED PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL | JUBILANT GENERICS LTD (IN) | 2019-07-17 | — | — | EP | disclosed |
| WO-2016147120-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE AZILSARTAN | SMILAX LABORATORIES LIMITED (IN) | 2016-09-22 | — | — | WO | disclosed |
| US-9233955-B2 | Process for the preparation of azilsartan medoxomil | JUBILANT LIFE SCIENCES, LTD. (IN) | 2016-01-12 | — | — | US | disclosed |
| EP-2673274-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL | Jubilant Life Sciences Limited (IN) | 2013-12-18 | — | — | EP | disclosed |
| US-20130317230-A1 | Process For The Preparation Of Azilsartan Medoxomil | Jubilant Generics Limited (IN) | 2013-11-28 | — | — | US | disclosed |
| WO-2012107814-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL | JUBILANT LIFE SCIENCES LIMITED (IN) | 2012-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130317230-A1 | Process For The Preparation Of Azilsartan Medoxomil | AZI2, KDM4B, KDM4A | ESR2 1991/4885HNF4A 655/4885BCAT2 1139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.